Paul A. Wagner Net Worth

What's Paul Wagner's mailing address?

Paul's mailing address filed with the SEC is C/O PFENEX INC., 10790 ROSELLE STREET, , SAN DIEGO, CA, 92121.

Insiders trading at Pfenex

Over the last 10 years, insiders at Pfenex have traded over $99,496,796 worth of Pfenex stock and bought 36,000 units worth $174,640 . The most active insiders traders include Chemical Co /De/ Dow, James C Gale oraz Healthcare Partners Accredi.... On average, Pfenex executives and independent directors trade stock every 46 days with the average trade being worth of $90,240,574. The most recent stock trade was executed by Asset Management Lpweiss An... on 29 September 2020, trading 100,000 units of PFNX stock currently worth $1,274,000.

What does Pfenex do?

Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.

Pfenex executives and stock owners

Pfenex executives and other stock owners filed with the SEC include:

• Shawn Scranton,
  Chief Operating Officer
• Susan A. Knudson,
  Chief Financial Officer
• Evert B. Schimmelpennink,
  See Remarks
• Patricia Lady,
  Chief Accounting Officer
• Jason Grenfell Gardner,
  Director
• Martin Brenner,
  Chief Scientific Officer
• Magda Marquet,
  Director
• Phillip M Schneider,
  Director
• Sigurdur O Olafsson,
  Director
• Hubert C Chen,
  Chief Medical Officer
• John Mack Taylor,
  Director
• Patrick K. Lucy,
  Chief Business Officer
• Robin Campbell,
  Director
• Lorianne Masuoka,
  Director
• Dennis M Fenton,
  Director
• William R Rohn,
  Director
• Henry W. Jr. Talbot,
  VP of Research & Operations
• Healthcare Partners Accredi...,
  10% owner
• Bertrand C. Liang,
  Chief Executive Officer
• Steven S. Sr. Sandoval,
  Chief Manufacturing Officer
• Paul A. Wagner,
  Chief Financial Officer
• Chemical Co /De/ Dow,
  10% owner
• Healthcare Partners Accredi...,
  
• James C Gale,
  Director
• Asset Management Lpweiss An...,
  
• Management, Llc Newtyn,
  10% owner